$8.1 Million Verdict for Lost Cancer Biopsy Specimen (IN)

Eric and Renee Flora felt reassured in the spring of 2004 when a local podiatrist removed a growth from her big toe and life for the New Carlisle couple returned to normal.

But when the growth resurfaced a year later, they received some frightening news. Renee Flora, a then 33-year-old nurse's aide and mother of two young girls, had malignant melanoma.

A St. Joseph Superior Court jury has found podiatrist Dr. W. Douglas Kolmodin liable for medical malpractice, concluding that Renee Flora's odds at beating the cancer were greatly reduced because he failed to have tissue from the excised growth tested for cancer.

Now in stage three of the cancer, she has just a 17 percent chance of living another 12 years, according to national cancer statistics, said her attorney, Rob Gonderman.

After a five-day trial last week, the jury awarded the Floras more than $8.1 million in damages.

The couple declined to comment on the verdict, as did Kolmodin.

Kolmodin's attorneys, W. Todd Woelfer and Georgianne Walker, did not return calls seeking comment.

During the trial and in sworn affidavits contained in court records, the Floras testified they saw Kolmodin place the lesion in a container, and he told them he would send it for testing.

That was the last day Kolmodin practiced in his office at 711 W. McKinley Ave. During the firm's move several days later to a building in the Edison Lakes area in Mishawaka, the specimen was apparently lost, Gonderman said.

Kolmodin, 37, testified in a deposition that a local boy's baseball team helped with the move, partly to show their gratitude for a donation he had made to the team.

Kolmodin denied the specimen was lost, according to court records. Rather, he said, it disintegrated upon removal, and there was nothing left to have tested. However, the three podiatrists who reviewed the case for the Indiana Department of Insurance concluded there should have been enough tissue for the test, Gonderman said.

Gonderman said he was pleased with the verdict, but noted he has a long fight ahead in trying to recover the damages.

Fortunately for the Floras, Gonderman said, it appears Kolmodin's former practice, Northern Indiana Foot & Ankle Associates, had failed to participate in the state program that caps malpractice damages at $1.25 million for all care providers involved in a case.

Kolmodin will be shielded by Indiana's $250,000 damages cap against individual doctors under the law.

Gonderman said Northern Indiana Foot & Ankle Associates' status is unclear. Kolmodin now works for South Bend Clinic, which has acquired the firm, Kolmodin testified at trial.

South Bend Tribune [2/24/08]

Alleged Misdiagnosis - Cancer Wrongful Death (Michigan)

FACTS: The estate of a patient who died from a rare form of cancer alleged the man's death was due to negligence of the man's treating podiatrist. Plaintiff claimed defendant violated the standard of care, but the jury disagreed with that argument and returned a verdict in favor of defendant.

Plaintiff's decedent, 59 year old Walter Chapton, presented to defendant podiatrist in May 2000 with a 3 cm. lump on the top of his right foot. Defendant diagnosed the lump as a ganglion cyst and was able to aspirate only a small amount of fluid from the lump. Defendant injected the lump with corticosteroids. Chapton returned to see defendant two weeks later. Defendant's notes indicated the cyst was somewhat decreased in size and he told decedent there was no need to undergo further treatment unless the cyst got bigger, became painful or changed in color. On May 17, 2001, Chapton returned to defendant as the lump had grown to 4" to 5" in length and 3" in diameter over the previous several months. Defendant recommended its removal, which was not accomplished until July 18, 2001. Pathologists identified the mass as a high-grade myxoid chondrosarcoma (cancer), for which surgery was futile as the cancer had already metastasized to Chapton's lungs. Chapton died in May 2002.

Plaintiff's experts opined that, had the cancer been diagnosed in or around May 2000, Chapton's chances of survival were 80% to 90%. However, when the diagnosis was made in July 2001, his survival chances were zero. Plaintiff alleged that, because defendant was unable to aspirate much fluid from the mass in May 2001, the standard of care required further testing, such as an MRI, ultrasound, or CT scan, or referral to an orthopedic surgeon.

Defendant contended that, despite retrospective knowledge that the diagnosis was incorrect, it was not a violation in the standard of care to miss the cancer. He claimed he was not negligent because primary cancerous lesions to the foot, , particularly chondrosarcoma, are extremely rare.

RESULT: Defense verdict

PLAINTIFF EXPERTS: Jonathan A. Haber, DPM, Caldwell, NJ, Charles F. Fenton, III, DPM, JD, Atlanta, GA, J. Sybil Biermann, MD, Ann Arbor, MI, Michael J. Kraut, MD, Southfield, MI

DEFENDANT EXPERTS: Charles G. Kissel, DPM, Warren, MI, Marshall Solomon, DPM, Farmington Hills, MI

Source; The Michigan Trial Reporter